Summit Financial’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $834K | Buy |
1,873
+233
| +14% | +$104K | 0.02% | 453 |
|
|
2025
Q1 | $795K | Sell |
1,640
-183
| -10% | -$88.7K | 0.02% | 415 |
|
|
2024
Q4 | $734K | Buy |
1,823
+444
| +32% | +$179K | 0.03% | 378 |
|
|
2024
Q3 | $641K | Buy |
1,379
+174
| +14% | +$80.9K | 0.03% | 333 |
|
|
2024
Q2 | $565K | Buy |
1,205
+663
| +122% | +$311K | 0.03% | 307 |
|
|
2024
Q1 | $227K | Sell |
542
-312
| -37% | -$130K | 0.01% | 355 |
|
|
2023
Q4 | $347K | Buy |
854
+239
| +39% | +$97.2K | 0.02% | 280 |
|
|
2023
Q3 | $214K | Buy |
+615
| New | +$214K | 0.02% | 314 |
|